These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10600)

  • 1. The clinical pharmacology of beta-adrenoceptor-blocking drugs.
    Conolly ME; Kersting F; Dollery CT
    Prog Cardiovasc Dis; 1976; 19(3):203-34. PubMed ID: 10600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension].
    Lydtin H
    Med Welt; 1975 Aug; 6(35):1487-92. PubMed ID: 240998
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro assessment of the selectivities of various beta-adrenergic blocking agents.
    Dreyer AC; Offermeier J
    Life Sci; 1980 Dec; 27(22):2087-92. PubMed ID: 6111008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
    Lowenthal DT; Saris SD; Packer J; Haratz A; Conry K
    Am J Med; 1984 Oct; 77(4A):119-27. PubMed ID: 6148890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenergic receptors and beta-blocking agents in coronary pathology].
    Chemin P; Rossi A
    Ann Cardiol Angeiol (Paris); 1974 Oct; 23(5):427-40. PubMed ID: 4155261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of adrenoreceptors (alpha and beta): its progress and clinical application].
    Furukawa T
    Nihon Rinsho; 1980 Sep; 38(9):3259-71. PubMed ID: 6114181
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta blockers: the extended family.
    Hager WD; Messineo FC; Katz AM
    Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenergic beta blocking agents in clinical medicine: hopes and disappointments].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(4):992-4. PubMed ID: 4156087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-blockaders. Their pharmacology and clinical use].
    Tomov L; Elenkova A; Nikolov GT
    Vutr Boles; 1978; 17(5):1-12. PubMed ID: 31033
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic blocking agents.
    Kendall MJ; Smith SR
    J Clin Hosp Pharm; 1983 Jun; 8(2):155-73. PubMed ID: 6135714
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta blocking drugs were introduced into clinical practice 15 years ago: myths and reality].
    Cocco G; Strozzi C
    Clin Ter; 1977 Jan; 80(1):67-89. PubMed ID: 16720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-receptor blockers in hypertension: nonselective or selective].
    Fennis JF; van 't Laar A
    Ned Tijdschr Geneeskd; 1978 Dec; 122(49):1924-5. PubMed ID: 31572
    [No Abstract]   [Full Text] [Related]  

  • 19. Rebound phenomena following withdrawal of long-term beta-adrenoceptor blockade.
    Hjemdahl P; Olsson G
    Acta Med Scand Suppl; 1982; 665():43-7. PubMed ID: 6130674
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.